ACGLN vs UTHR · P/E 3.6, $15.30B cap vs P/E 20, rev $1.56B
Arch Capital Group Ltd (ACGLN) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Arch Capital Group Ltd (ACGLN) is a insurance - diversified company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
ACGLN does not have a complete income-statement cache yet.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
ACGLN currently screens at market cap $15.30B and trailing P/E 3.6. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the ACGLN and UTHR stock pages for the full models.
Not investment advice.